- Home
- China
- World
- Asia-Pacific
- Americas
- Europe
- Middle-East and Africa
- Politics
- Business
- Opinions
- Tech & Sci
- Culture
- Sports
- Travel
- Nature
- Picture
- Video
- Live
- TV
- Radio
- Specials
- Learn Chinese
Video
20:44, 01-Apr-2022
5 companies in China approved to produce low cost Paxlovid
Updated
21:51, 01-Apr-2022
Share
Copied
02:30
The UN-backed public health organization, the Medicines Patent Pool, has given approval to 35 companies, including five in China, to manufacture a generic version of Pfizer's COVID-19 antiviral oral pill. The low-cost version of these pills will be supplied to 95 low and middle income countries.
